|
Volumn 53, Issue , 2012, Pages 28-40
|
Synthesis and antitumor evaluation of novel Benzo[d]pyrrolo[2,1-b]thiazole derivatives
|
Author keywords
Antitumor agents; benzo d pyrrolo 2,1 b thiazol; Cell cycle; Cytotoxicity; DNA cross linking
|
Indexed keywords
3 (3 CHLORO 4 FLUOROBENZOYL) 2,3 DIHYDROBENZO(D)THIAZOLE 2 CARBONITRILE;
3 (3,4 DICHLOROBENZOYL) 2,3 DIHYDROBENZO(D)THIAZOLE 2 CARBONITRILE;
3 (3,4 DIFLUOROBENZOYL) 2,3 DIHYDROBENZO(D)THIAZOLE 2 CARBONITRILE;
3 (3,4 DIMETHOXYBENZOYL) 2,3 DIHYDROBENZO(D)THIAZOLE 2 CARBONITRILE;
3 (3,4,5 TRIMETHOXYBENZOYL) 2,3 DIHYDROBENZO(D)THIAZOLE 2 CARBONITRILE;
3 (4 CHLOROBENZOYL) 2,3 DIHYDROBENZO(D)THIAZOLE 2 CARBONITRILE;
3 (4 FLUOROBENZOYL) 2,3 DIHYDROBENZO(D)THIAZOLE 2 CARBONITRILE;
3 (4 METHOXYBENZOYL) 2,3 DIHYDROBENZO(D)THIAZOLE 2 CARBONITRILE;
3 (CYCLOPROPANECARBONYL) 2,3 DIHYDROBENZO(D)THIAZOLE 2 CARBONITRILE;
3 ACETYL 2,3 DIHYDROBENZO(D)THIAZOLE 2 CARBONITRILE;
[1 (4 CHLOROPHENYL)BENZO(D)PYRROLO(2,1 B)THIAZOLE 2,3 DIYL]BIS(METHYLENE)BIS(ETHYLCARBAMATE);
[1 (4 CHLOROPHENYL)BENZO(D)PYRROLO(2,1 B)THIAZOLE 2,3 DIYL]BIS(METHYLENE)BIS(ISO PROPYLCARBAMATE);
[1 (4 FLUOROPHENYL)BENZO(D)PYRROLO(2,1 B)THIAZOLE 2,3 DIYL]BIS(METHYLENE)BIS(ETHYLCARBAMATE);
[1 (4 FLUOROPHENYL)BENZO(D)PYRROLO(2,1 B)THIAZOLE 2,3 DIYL]BIS(METHYLENE)BIS(ISO PROPYLCARBAMATE);
ANTINEOPLASTIC AGENT;
CISPLATIN;
DIMETHYL 1 (3 CHLORO 4 FLUOROPHENYL)BENZO(D)PYRROLO(2,1 B)THIAZOLE 2,3 DICARBOXYLATE;
DIMETHYL 1 (3,4 DICHLOROPHENYL)BENZO(D)PYRROLO(2,1 B)THIAZOLE 2,3 DICARBOXYLATE;
DIMETHYL 1 (3,4 DIMETHOXYPHENYL)BENZO(D)PYRROLO(2,1 B)THIAZOLE 2,3 DICARBOXYLATE;
DIMETHYL 1 (3,4,5 TRIMETHOXYPHENYL)BENZO(D)PYRROLO(2,1 B)THIAZOLE 2,3 DICARBOXYLATE;
DIMETHYL 1 (4 CHLOROPHENYL)BENZO(D)PYRROLO(2,1 B)THIAZOLE 2,3 DICARBOXYLATE;
DIMETHYL 1 (4 FLUOROPHENYL)BENZO(D)PYRROLO(2,1 B)THIAZOLE 2,3 DICARBOXYLATE;
DIMETHYL 1 METHYLBENZO(D)PYRROL(2,1 B)THIAZOLE 2,3 DICARBOXYLATE;
PACLITAXEL;
THIAZOLE DERIVATIVE;
UNCLASSIFIED DRUG;
VINBLASTINE;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
BODY WEIGHT;
BREAST CARCINOMA;
CANCER GROWTH;
CANCER INHIBITION;
CANCER REGRESSION;
CELL CYCLE G2 PHASE;
CELL CYCLE M PHASE;
CELL CYCLE PROGRESSION;
CELL CYCLE S PHASE;
CELL PROLIFERATION;
CHEMICAL REACTION;
COLON CARCINOMA;
COMPETITIVE INHIBITION;
CONTROLLED STUDY;
CYTOTOXICITY;
DNA CROSS LINKING;
DRUG EFFICACY;
DRUG SYNTHESIS;
HUMAN;
HUMAN CELL;
HYDROGENATION;
IN VITRO STUDY;
LUNG CARCINOMA;
LYMPHATIC LEUKEMIA;
MAXIMUM TOLERATED DOSE;
MOUSE;
MOUTH CARCINOMA;
NONHUMAN;
PROSTATE CARCINOMA;
STRUCTURE ACTIVITY RELATION;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CELL CYCLE;
CELL LINE, TUMOR;
CELL PROLIFERATION;
CHEMISTRY TECHNIQUES, SYNTHETIC;
DNA;
HUMANS;
INHIBITORY CONCENTRATION 50;
MALE;
MICE;
THIAZOLES;
XENOGRAFT MODEL ANTITUMOR ASSAYS;
|
EID: 84861586195
PISSN: 02235234
EISSN: 17683254
Source Type: Journal
DOI: 10.1016/j.ejmech.2012.03.030 Document Type: Article |
Times cited : (35)
|
References (26)
|